Trial Profile
Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Oct 2023
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms BOSS PD
- 23 Oct 2023 Status changed from active, no longer recruiting to completed.
- 14 Aug 2023 Status changed from recruiting to active, no longer recruiting.
- 06 Jan 2023 Planned End Date changed from 31 Mar 2023 to 30 Sep 2023.